These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 979659)

  • 1. The effects of acute and chronic insulin administration on plasma IRG levels in human diabetes.
    Raskin P; Aydin I; Unger RH
    Metabolism; 1976 Nov; 25(11 Suppl 1):1531-3. PubMed ID: 979659
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of insulin on the response of immunoreactive glucagon to an intravenous glucose load in human diabetes.
    Yamamoto T; Raskin P; Aydin I; Unger R
    Metabolism; 1979 May; 28(5):568-74. PubMed ID: 449698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of short-term intravenous insulin administration on the glucagon response to a carbohydrate meal in adult onset and juvenile type diabetes.
    Aydin I; Raskin P; Unger RH
    Diabetologia; 1977 Dec; 13(6):629-36. PubMed ID: 590654
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of insulin therapy on the profiles of plasma immunoreactive glucagon in juvenile-type and adult-type diabetics.
    Raskin P; Unger RH
    Diabetes; 1978 Apr; 27(4):411-9. PubMed ID: 640246
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus.
    Gerich JE; Langlois M; Noacco C; Lorenzi M; Karam JH; Korsham PH
    J Clin Invest; 1976 Aug; 58(2):320-5. PubMed ID: 783198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics.
    Raskin P; Fujita Y; Unger RH
    J Clin Invest; 1975 Nov; 56(5):1132-8. PubMed ID: 1184740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon and diabetes mellitus.
    Herlihy B
    Crit Care Nurse; 1983; 3(1):38-43. PubMed ID: 6402337
    [No Abstract]   [Full Text] [Related]  

  • 8. Glucagon and insulin relationships in genetically diabetic (db/db) and in streptozotocin-induced diabetic mice.
    Stearns SB; Benzo CA
    Horm Metab Res; 1978 Jan; 10(1):20-3. PubMed ID: 147231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discrepancy of fasting plasma glucagon levels measured by different glucagon antisera.
    Tahara Y; Tanaka A; Yamamoto Y; Fukuda M; Kumahara Y; Shima K
    Diabetes Res; 1988 Apr; 7(4):179-83. PubMed ID: 3402167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of plasma glucagon: patterns in patients with chronic renal failure and diabetes.
    Kuku SF; Zeidler A; Emmanouel DS; Katz AI; Rubenstein AH
    J Clin Endocrinol Metab; 1976 Jan; 42(1):173-6. PubMed ID: 1249185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of pancreatic alpha cell function in normal and diabetic subjects.
    Unger RH; Aguilar-Parada E; Müller WA; Eisentraut AM
    J Clin Invest; 1970 Apr; 49(4):837-48. PubMed ID: 4986215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perfect normalization of excessive glucagon responses to intravenous arginine in human diabetes mellitus with the artificial beta-cell.
    Kawamori R; Shichiri M; Kikuchi M; Yamasaki Y; Abe H
    Diabetes; 1980 Sep; 29(9):762-5. PubMed ID: 7002690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects.
    Sherwin RS; Fisher M; Hendler R; Felig P
    N Engl J Med; 1976 Feb; 294(9):455-61. PubMed ID: 1246330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of acute insulin withdrawal and administration on plasma glucagon responses to intravenous arginine in insulin-dependent diabetic subjects.
    Gerich JE; Lorenzi M; Tsalikian E; Bohannon NV; Schneider V; Karam JH; Forsham PH
    Diabetes; 1976 Oct; 25(10):955-60. PubMed ID: 976604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in glucagon levels after four to five weeks of glucoregulation by portable insulin infusion pumps.
    Raskin P; Pietri A; Unger R
    Diabetes; 1979 Nov; 28(11):1033-5. PubMed ID: 488544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normalization of the paradoxic secretion of glucagon in diabetics who were controlled by the artificial beta cell.
    Shichiri M; Kawamori R; Abe H
    Diabetes; 1979 Apr; 28(4):272-5. PubMed ID: 374171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose clamp investigations. The ups and downs.
    Boyle PJ
    Diabetes Care; 1994 Mar; 17(3):239-41. PubMed ID: 8174455
    [No Abstract]   [Full Text] [Related]  

  • 18. Suppressibility of glucagon secretion by glucose in juvenile diabetes.
    Sperling MA; Aleck K; Voina S
    J Pediatr; 1977 Apr; 90(4):543-7. PubMed ID: 839365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of adrenergic beta-blocking agents on the serum insulin and glucagon response to oral glucose load in normal and diabetic subjects].
    Ferlito S; Volpicelli D; Del Campo F; Romano F; Modica L
    Clin Ter; 1981 May; 97(4):333-47. PubMed ID: 6113914
    [No Abstract]   [Full Text] [Related]  

  • 20. Exaggerated glucagon secretion in diabetic and non-diabetic subjects with surgical porto-caval anastomosis.
    Fallucca F; Ziparo V; Giangrande L; Menzinger G; Stipa S
    Horm Metab Res; 1981 Oct; 13(10):545-7. PubMed ID: 7298009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.